CLOSE

Benchmark Investments

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)

very highequitypharma & health care
37.21 -0.37(-0.98%) NAV as on 27 Mar 2026
-3.43 % 1 M
2.25 % 1 Y
26.34 % 3 Y

Growth Chart of the Scheme vis a vis benchmark

  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y

SCHEME DETAILS

Expenses Ratio :

1.86

As on 28 Feb, 2026
Age :

7 yrs 8 m

Since 13 07 ,2018
Exit Load :

1%

AUM :

6,801.16 Crs

Portfolio Price To Book Value :

4.98

Investing Style :

Large Growth

Min. Investment :

SIP 100 & Lumpsum 5000

Category :

sector funds

Fund Manager :

Dharmesh Kakkad

Launch Date :

13-Jul-18

Scheme Benchmark :

NA

FUND OBJECTIVE

To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance that the investment objectives of the scheme will be realized.

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

LATEST ASSET & PORTFOLIO ALLOCATION

as on Feb 28 ,2026
Debt 0.03 %
Others 1.99 %
Equity 97.98 %

TOP HOLDINGS

Sun Pharmaceutical Industries...11.21 %
Cipla Ltd.9.40 %
Mankind Pharma Ltd.7.64 %
Dr. Reddy's Laboratories Ltd.6.52 %
Biocon Ltd.6.20 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs83.57
Business Support4.93
Hospital & Healthcare Services3.44
Retailing2.54
Trading1.46
See All Sectors

5-YEARS HISTORY

Financial Year2021-20222022-20232023-20242024-20252025-2026
NAV in Rs (as on 27-Mar-2026)19.6918.6430.2036.2037.21
Net Assets(Rs Crores) (as on 27-Mar-2026) 2500.42 2594.59 3772.32 4914.64 6801.16
Scheme Returns(%)(Absolute)12.51-5.3861.1518.223.82
B'mark Returns(%)(Absolute)NANANANANA
Category Rank47/7563/7612/906/10236/120

Quarterly Performance - Last 5 Years (Absolute Ret. In %)

Financial Year Q1 Q2 Q3 Q4
2025-20268.81-1.192.29NA
2024-20256.6621.112.87-9.79
2023-202416.9511.7911.1611.48
2022-2023-8.796.630.10-2.76
2021-202217.814.01-1.46-6.01

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity37.21-0.37(-0.98%)NAV As on 27 Mar, 202613-Jul-2018Inception Date6,801.16AUM In Cr.2.25%1Y26.34%3Y17.07%5Y18.58%Since Inception
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity30.55-0.19(-0.62%)NAV As on 27 Mar, 202610-Jul-2019Inception Date854.04AUM In Cr.4.23%1Y23.50%3Y14.21%5Y18.09%Since Inception
Nippon India Pharma Fund(G)Very HighEquity495.60-4.71(-0.94%)NAV As on 27 Mar, 202605-Jun-2004Inception Date8,306.35AUM In Cr.2.84%1Y22.57%3Y15.26%5Y19.59%Since Inception

BENCHMARK INVESTMENTS

Benchmark Investments, 6 Sector II Shanti Niketan, Govindpura Bhopal, Bhopal-462023, India. +91-755-4938282/+91-9826310337 hello@benchmarkinvestments.in.
Downloads
Quick Links
Useful Links

Mutual fund and other investments are always subject to market risks. Please read all, Scheme Information Documents (SID), Key Information Memorandum (KIM), Addendums(if any) issued there to from time to time and any other related documents or information carefully before investing. Past performance is not indicative or assurance of future performance or returns. Please consider your specific investment requirements before choosing a fund.

For any grievances, investors can contact at: hello@benchmarkinvestments.in,  Tel: +91-755-4938282 / +91-9826310337.
©  Copyrights 2022 , Benchmark Investments | All Rights Reserved |  Designed, Developed & Content Powered by Accord Fintech Pvt Ltd